The NRF2 protein is activated by tumor suppressor gene products such as breast cancer susceptibility gene I and p21Cip1 by inhibiting KEAP1/NRF2 complex formation in microenvironmental cells in tumors [41,42]. This evidence concerns the gene CDKN1A and cancer.